Ashleigh Lynn Leuck, MA, LPA, BCBA, HSP-A | |
7444 Chipley Dr, Wilmington, NC 28411-6214 | |
(910) 390-6621 | |
(910) 390-6627 |
Full Name | Ashleigh Lynn Leuck |
---|---|
Gender | Female |
Speciality | Behavior Analyst |
Location | 7444 Chipley Dr, Wilmington, North Carolina |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013497379 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC2200X | Psychologist - Clinical Child & Adolescent | 5384 (North Carolina) | Secondary |
103K00000X | Behavior Analyst | 1-18-31992 (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ashleigh Lynn Leuck, MA, LPA, BCBA, HSP-A 7444 Chipley Dr, Wilmington, NC 28411-6214 Ph: (910) 390-6621 | Ashleigh Lynn Leuck, MA, LPA, BCBA, HSP-A 7444 Chipley Dr, Wilmington, NC 28411-6214 Ph: (910) 390-6621 |
News Archive
The U.S. Food and Drug Administration, SNM and the Radiological Society of North America (RSNA) are hosting a joint two-topic workshop, April 13-14, 2010 at the Natcher Conference Center of the National Institutes of Health, Bethesda, Md. The first day of the workshop will focus on general issues of standardization to control variability and inconsistency in methods of acquisition, interpretation and analysis of images in clinical trials.
People recover faster after surgery for ankle fracture if they are given a cast or splint that can be removed to let them exercise the ankle, than if their foot is placed in an immobilising plaster cast. If the fracture is stable, then encouraging them to walk soon after surgery is also beneficial.
Researchers at the University of California, San Diego School of Medicine have identified a link between patients who undergo total nephrectomy - complete kidney removal - and erectile dysfunction.
Drugs like crizotinib are used to treat patients with ROS1-positive lung cancer. But which patients are ROS1-positive? A University of Colorado Cancer Center study published in the Journal of Thoracic Oncology shows that common laboratory tests used to determine ROS1 status all have inherent limitations that can lead to false-negative results.
› Verified 6 days ago